Detalles de la búsqueda
1.
A Bacterial and Ganglioside-based Nanoparticle Initiates Reprogramming of Macrophages and Promotes Antitumor Phenotypes.
J Immunol
; 212(3): 475-486, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38117752
2.
VSSP-activated macrophages mediate senescence and tumor inhibition in a preclinical model of advanced prostate cancer.
Cell Commun Signal
; 21(1): 76, 2023 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37055829
3.
VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients.
Cancer Immunol Immunother
; 71(10): 2355-2369, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35166871
4.
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.
Immunity
; 32(6): 790-802, 2010 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-20605485
5.
Novel Adjuvant Based on the Pore-Forming Protein Sticholysin II Encapsulated into Liposomes Effectively Enhances the Antigen-Specific CTL-Mediated Immune Response.
J Immunol
; 198(7): 2772-2784, 2017 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28258198
6.
Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.
Cell Mol Life Sci
; 72(7): 1231-48, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25487607
7.
Inhibition of tumor-induced myeloid-derived suppressor cell function by a nanoparticulated adjuvant.
J Immunol
; 186(1): 264-74, 2011 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21135171
8.
Murine Mammary Carcinoma Induces Chronic Systemic Inflammation and Immunosuppression in BALB/c Mice.
J Breast Cancer
; 25(3): 218-232, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35657001
9.
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC.
Front Oncol
; 12: 958043, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35992783
10.
Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator.
J Immunother Cancer
; 10(9)2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36150744
11.
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
Eur J Immunol
; 40(1): 22-35, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19941314
12.
Sticholysins, pore-forming proteins from a marine anemone can induce maturation of dendritic cells through a TLR4 dependent-pathway.
Mol Immunol
; 131: 144-154, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33422341
13.
A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapy.
Oncoimmunology
; 9(1): 1770565, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32923126
14.
Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function.
Int Immunol
; 20(4): 591-600, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18310617
15.
Antitumor effects of the GM3(Neu5Gc) ganglioside-specific humanized antibody 14F7hT against Cmah-transfected cancer cells.
Sci Rep
; 9(1): 9921, 2019 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31289278
16.
Cancer-induced systemic myeloid dysfunction: Implications for treatment and a novel nanoparticle approach for its correction.
Semin Oncol
; 45(1-2): 84-94, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30318088
17.
Complete antitumor protection by perioperative immunization with GM3/VSSP vaccine in a preclinical mouse melanoma model.
Clin Cancer Res
; 12(23): 7092-8, 2006 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17145833
18.
Antitumor and cytotoxic properties of a humanized antibody specific for the GM3(Neu5Gc) ganglioside.
Immunobiology
; 220(12): 1343-50, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26224247
19.
Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.
Hum Vaccin Immunother
; 10(11): 3251-60, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25483674
20.
Very small size proteoliposomes abrogate cross-presentation of tumor antigens by myeloid-derived suppressor cells and induce their differentiation to dendritic cells.
J Immunother Cancer
; 2: 5, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24829762